Adiponectin, a key adipokine in obesity related liver diseases.

URN to cite this document:: urn:nbn:de:bvb:355-epub-237576
DOI to cite this document:: 10.5283/epub.23757

Buechler, Christa ; Wanninger, Josef ; Neumeier, Markus

Preview

PDF
(987kB)

Date of publication of this fulltext: 11 Apr 2012 09:01

Alternative links to fulltext:Pubmed DOI

Details

Preview

Export bibliographical data

Abstract

Non-alcoholic fatty liver disease (NAFLD) comprising hepatic steatosis, non-alcoholic steatohepatitis (NASH), and progressive liver fibrosis is considered the most common liver disease in western countries. Fatty liver is more prevalent in overweight than normal-weight people and liver fat positively correlates with hepatic insulin resistance. Hepatic steatosis is regarded as a benign stage of ...